全文获取类型
收费全文 | 1224530篇 |
免费 | 105818篇 |
国内免费 | 27537篇 |
专业分类
耳鼻咽喉 | 15551篇 |
儿科学 | 29353篇 |
妇产科学 | 29154篇 |
基础医学 | 163403篇 |
口腔科学 | 31352篇 |
临床医学 | 127227篇 |
内科学 | 213060篇 |
皮肤病学 | 20916篇 |
神经病学 | 87496篇 |
特种医学 | 48605篇 |
外国民族医学 | 395篇 |
外科学 | 167871篇 |
综合类 | 94031篇 |
现状与发展 | 88篇 |
一般理论 | 294篇 |
预防医学 | 93914篇 |
眼科学 | 30852篇 |
药学 | 104480篇 |
432篇 | |
中国医学 | 25850篇 |
肿瘤学 | 73561篇 |
出版年
2022年 | 16325篇 |
2021年 | 23017篇 |
2020年 | 17530篇 |
2019年 | 16708篇 |
2018年 | 19202篇 |
2017年 | 17247篇 |
2016年 | 17081篇 |
2015年 | 24244篇 |
2014年 | 31659篇 |
2013年 | 35424篇 |
2012年 | 50415篇 |
2011年 | 55024篇 |
2010年 | 34993篇 |
2009年 | 30234篇 |
2008年 | 43385篇 |
2007年 | 45102篇 |
2006年 | 44093篇 |
2005年 | 42917篇 |
2004年 | 35988篇 |
2003年 | 34713篇 |
2002年 | 31649篇 |
2001年 | 43709篇 |
2000年 | 44164篇 |
1999年 | 38797篇 |
1998年 | 14313篇 |
1997年 | 13494篇 |
1996年 | 12340篇 |
1995年 | 11648篇 |
1994年 | 10793篇 |
1992年 | 28878篇 |
1991年 | 28038篇 |
1990年 | 27231篇 |
1989年 | 26077篇 |
1988年 | 24372篇 |
1987年 | 23926篇 |
1986年 | 22586篇 |
1985年 | 21681篇 |
1984年 | 16704篇 |
1983年 | 14234篇 |
1979年 | 16857篇 |
1978年 | 12175篇 |
1977年 | 10231篇 |
1976年 | 9358篇 |
1975年 | 10172篇 |
1974年 | 12674篇 |
1973年 | 12163篇 |
1972年 | 11573篇 |
1971年 | 10701篇 |
1970年 | 10237篇 |
1969年 | 9928篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
55.
56.
Emma J. Kilford Iroise Dumontheil Nicholas W. Wood Sarah-Jayne Blakemore 《Social cognitive and affective neuroscience》2015,10(6):777-782
The catechol-O-methyltransferase (COMT) enzyme is a major determinant of prefrontal dopamine levels. The Val158Met polymorphism affects COMT enzymatic activity and has been associated with variation in executive function and affective processing. This study investigated the effect of COMT genotype on the flexible modulation of the balance between processing self-generated and processing stimulus-oriented information, in the presence or absence of affective distractors. Analyses included 124 healthy adult participants, who were also assessed on standard working memory (WM) tasks. Relative to Val carriers, Met homozygotes made fewer errors when selecting and manipulating self-generated thoughts. This effect was partly accounted for by an association between COMT genotype and visuospatial WM performance. We also observed a complex interaction between the influence of affective distractors, COMT genotype and sex on task accuracy: male, but not female, participants showed a sensitivity to the affective distractors that was dependent on COMT genotype. This was not accounted for by WM performance. This study provides novel evidence of the role of dopaminergic genetic variation on the ability to select and manipulate self-generated thoughts. The results also suggest sexually dimorphic effects of COMT genotype on the influence of affective distractors on executive function. 相似文献
57.
58.
59.
Peng Li Sha-Sha Tao Meng-Qin Zhao Jun Li Xiu Wang Hai-Feng Pan 《Immunological investigations》2015,44(7):603-615
Objective: Association of matrix metalloproteinases (MMPs) gene polymorphisms with rheumatoid arthritis is controversial. We conduct a meta-analysis to clarify this dispute.Methods: We systematically searched the electronic PUBMED, EMBASE and CNKI databases for research articles about MMPs (MMP-1, MMP-2, MMP-3, MMP-9) gene polymorphisms and rheumatoid arthritis (RA) up to January 2015. According to the heterogeneity, fixed-effects or random-effects models were used to calculate crude odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: A total of 11 articles involving 2143 cases and 2049 controls were included in this meta-analysis. Overall, no significant associations were observed between MMP-1-1607 1G/2G polymorphism and RA. Stratification by ethnicity, no significant associations were observed in Caucasian populations. Similarly, no significant associations were observed between MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms and RA in overall and Caucasian populations, respectively. However, a weak association was found between MMP-2-1306 C/T polymorphism and RA (C vs. T, OR?=?0.813, 95%CI?=?0.694–0.953, p?=?0.010) in overall populations.Conclusions: The present meta-analysis suggests that MMP-1-1607 1G/2G, MMP-3-1171 5A/6A, MMP-9-1562 C/T polymorphisms are not associated with the susceptibility of RA, but MMP-2 -1306 C/T is weakly associated with susceptibility to RA. Further studies with more sample size are needed for definitive conclusions. 相似文献
60.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献